Hangzhou Jiuyuan Gene Engineering Co., Ltd
Is this your company? Claim this profile
Advanced Modalities
Company Overview
About
Hangzhou Jiuyuan Gene Engineering Co., Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:China
Founded:1999
Employees:318
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval JI1IZB
Health Canada · #APR-DTBNRSMP · 2018-07-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-TGCZKPL7
Issued: 2020-02-10
Expires: 2025-12-26
Health Canada GMP
Health Canada
Cert #: CERT-7EXMPFA7
Issued: 2020-12-28
Expires: 2025-06-21
Loading CDMO intelligence...
Key facts about Hangzhou Jiuyuan Gene Engineering Co., Ltd
- Hangzhou Jiuyuan Gene Engineering Co., Ltd is headquartered in China.
- Hangzhou Jiuyuan Gene Engineering Co., Ltd was founded in 1999.
- Hangzhou Jiuyuan Gene Engineering Co., Ltd has 318 employees.
- Hangzhou Jiuyuan Gene Engineering Co., Ltd's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Hangzhou Jiuyuan Gene Engineering Co., Ltd
Directory pages this company appears in, each with the full list of matching manufacturers.